News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Kite Pharma
NEWS
JOBS
IN THE PRESS
NEWS
Biotech Beach
SoCal’s Kite Pharma, Inc. Talks With Insurers to Avoid Gilead Sciences, Inc. Price War
January 15, 2015
·
2 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Biotech Beach
Kite Pharma Announces Publication Of T-Cell Therapy Targeting Mutant KRAS In Cancer By The NCI In The New England Journal of Medicine
December 12, 2016
·
3 min read
Drug Development
Kite Pharma Presents Results Of Multi-Center Pivotal ZUMA-1 Trial Of Axicabtagene Ciloleucel (KTE-C19) In Aggressive Non-Hodgkin Lymphoma As Late-Breaking Abstract At Annual Meeting Of American Society of Hematology
December 6, 2016
·
5 min read
FDA
Kite Pharma Initiates Rolling Submission Of U.S. Biologics License Application (BLA) For KTE-C19, Its Investigational Anti-CD19 CAR-T Therapy, For The Treatment Of Patients With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma (NHL)
December 5, 2016
·
3 min read
Business
Kite Pharma Appoints Jian Irish, Phd As Senior Vice President Of Supply Chain
December 1, 2016
·
4 min read
Drug Development
Kite Pharma To Present Interim Results From The ZUMA-1 Pivotal Trial Of KTE-C19 In A Late-Breaking Session At The 2016 American Society of Hematology Annual Meeting
November 21, 2016
·
4 min read
Business
Kite Pharma Pushes Back Timeline Slightly for Filing of Its Pioneering CAR-T Candidate KTE-C19
November 9, 2016
·
7 min read
Business
Kite Pharma To Report Third Quarter 2016 Financial Results On November 9, 2016
November 2, 2016
·
1 min read
Drug Development
Kite Pharma Details KTE-C19 Launch Preparedness And Near-Term, Next Generation CAR/TCR Product Candidates At Investor Day
October 19, 2016
·
6 min read
Business
Kite Pharma Appoints Chris Nowers As Head Of Europe To Lead Commercial Operations And Advance The Company’s CAR/TCR Therapy Portfolio In The Region
October 13, 2016
·
1 min read
Biotech Bay
Kite Pharma To Host Investor Day On October 18, 2016 Spotlighting An Industry-Leading CAR/TCR Pipeline, Next Generation Research And Development, And KTE-C19 Launch Readiness
October 11, 2016
·
1 min read
